LanTing Capital
Hangzhou, Zhejianglantingcapital.com
Overview
A cross-border, healthcare and pharmaceutical focused strategic consulting and investment firm founded by pharmaceutical veterans and asset management experts. The firm leverages its industry knowledge and network across the US, China, and Europe. Its services include Private Equity, Financial Advisory, and Strategic Consulting.
Portfolio Companies
11
Website
lantingcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Insilico Medicine | Jun 2022 | Series D | Co-investor |
| Rona Therapeutics | Apr 2022 | Series A | Co-investor |
| Laviana Pharma | Oct 2021 | Series C | Co-investor |
| Duckbill Network Tech | Mar 2021 | Series B | Co-investor |
| ImmVira | Dec 2020 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
